Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease 3. Rapid correction of low vitamin D status in nursing home residents 4. 2008 Exclusive Survey—Earnings: Good news for primary care income 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
Long-term experience of pegvisomant therapy as a treatment for acromegaly
Clinical Endocrinology, 06/18/09
Higham CE et al. - This long-term experience in 57 patients indicates pegvisomant to be effective, safe and well-tolerated. Raised transaminases occurred within the first month of therapy in two patients, and tumour growth was seen in one patient (tumour was growing prior to pegvisomant). In two patients increasing doses of pegvisomant were required to keep IGF-I within the target range.
Related Articles
The Exon 3-Deleted Growth Hormone Receptor Is Associated with Better Response to Pegvisomant Therapy in Acromegaly
Journal of Clinical Endocrinology and Metabolism, 11/12/09
Relevance Score: 88%
The Exon-3 Deleted Growth Hormone Receptor Polymorphism Predisposes to Long-Term Complications of Acromegaly
Journal of Clinical Endocrinology and Metabolism, 11/12/09
Relevance Score: 87%
Discordant Nadir GH After Oral Glucose and IGF-I Levels on Treated Acromegaly: Refining the Biochemical Markers of Mild Disease Activity
Hormone and Metabolic Research, 10/06/09
Relevance Score: 87%
Prevalence of mental disorders in acromegaly: a cross-sectional study in 81 acromegalic patients
Clinical Endocrinology, 10/15/09
Relevance Score: 85%
ACTH Deficiency, Higher Doses of Hydrocortisone Replacement, and Radiotherapy Are Independent Predictors of Mortality in Patients with Acromegaly
Journal of Clinical Endocrinology and Metabolism, 10/14/09
Relevance Score: 85%
Today in Endocrine Oncology...keeping you current
Receive free subspecialty "5-minute updates" via email
Thyroid follicular neoplasm: Analysis by fine needle aspiration cytology, frozen section, and histopathology
Diagnostic Cytopathology, 12/18/09
Metastatic signet ring cell carcinoma presenting as a thyroid nodule: Report of a case with fine-needle aspiration cytology
Diagnostic Cytopathology, 12/18/09
Diagnostic Accuracy of rhTSH Test with Neck Ultrasonography in Differentiated Thyroid Cancer Follow-up
Experimental and Clinical Endocrinology & Diabetes, 12/17/09
Today in Neuroendocrinology...keeping you current
Receive free subspecialty "5-minute updates" via email
Evaluation of antioxidant systems in pituitary-adrenal axis diseases
Pituitary, 12/18/09
A heritable predisposition to pituitary tumors
Pituitary, 12/18/09
The risk for breast cancer is not evidently increased in women with hyperprolactinemia
Pituitary, 12/18/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
Temozolomide (Temodar) and capecitabine (Xeloda) treatment of an aggressive corticotroph pituitary tumor
Pituitary, 12/18/09
New therapies for the treatment of type 2 diabetes: an update
European Diabetes Nursing, 12/18/09
Comparison of the efficacy of administering a combination of ezetimibe plus fenofibrate versus atorvastatin monotherapy in the treatment of dyslipidemia
Lipids in Health and Disease, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor


See Latest Articles


